PANVAX pandemic influenza vaccine, adjuvanted 10 ml suspension for injection vial

Land: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Kauptu það núna

Download Opinber matsskýrsla (PAR)
30-11-2017

Virkt innihaldsefni:

Influenza virus haemagglutinin, Quantity: 30 microgram

Fáanlegur frá:

Seqirus Pty Ltd

INN (Alþjóðlegt nafn):

Influenza virus haemagglutinin

Lyfjaform:

Injection, suspension

Samsetning:

Excipient Ingredients: aluminium; dibasic sodium phosphate; calcium chloride dihydrate; potassium chloride; thiomersal; monobasic sodium phosphate; monobasic potassium phosphate; sodium chloride

Stjórnsýsluleið:

Intramuscular

Einingar í pakka:

50 x 10 mL Vial

Gerð lyfseðils:

(S4) Prescription Only Medicine

Ábendingar:

Prophylaxis of influenza in an officially declared pandemic situation. Pandemic influenza vaccine should be used in accordance with Australian Health Authorities' recommendations, taking into account the recommendation of the World Health Organisation.

Vörulýsing:

Visual Identification: Creamy / white opaque liquid; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Leyfisstaða:

Registered

Leyfisdagur:

2008-06-12